HNMT and cancer: Conversely, Kuo and colleagues found that patients with NSCLC who have low miR-223 levels had higher histamine N-methyltransferase (HNMT) expression in cancer tissue (compared to normal tissue) and a worse prognosis than those with low HNMT and higher miR-223 expression in their cancer tissue.